A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial
一项评估加尼妥单抗或安慰剂联合吉西他滨作为转移性胰腺腺癌一线治疗方案的3期随机、双盲、安慰剂对照试验:GAMMA试验
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdv027
Fuchs, C S; Azevedo, S; Okusaka, T; Van Laethem, J-L; Lipton, L R; Riess, H; Szczylik, C; Moore, M J; Peeters, M; Bodoky, G; Ikeda, M; Melichar, B; Nemecek, R; Ohkawa, S; Świeboda-Sadlej, A; Tjulandin, S A; Van Cutsem, E; Loberg, R; Haddad, V; Gansert, J L; Bach, B A; Carrato, A